Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • apadr007
    Member
    • Oct 2011
    • 21

    #1

    Cuffdiff multiple accession numbers

    Hello,

    I wanted to know why the Cuffdiff "gene.exp.diff" and "cds.diff" files were producing multiple accession numbers in the same row. For example:


    XLOC_000122 - - XLOC_000122 AGAP004916,AGAP004918 TSS334,TSS335



    As you can tell, this is a single row with two "AGAP" accession numbers, separated by a comma. Why is this happening?

    Thanks.
  • NM_010117
    Member
    • Oct 2010
    • 14

    #2
    This is most likely due to it reporting the different isoforms that are part of that gene. Most mammalian genes have at least two isoforms, if not three or four (or more!). That is why you are also getting two different transcription start sites (TSS): TSS334 and TSS335. One is for AGAP004916 and the other is the transcription start site for AGAP004918.
    Last edited by NM_010117; 12-13-2011, 11:30 AM. Reason: grammar

    Comment

    • apadr007
      Member
      • Oct 2011
      • 21

      #3
      This makes absolutely no sense to me. Cuffdiff generates an isoform file so it should simply report isoforms of a particular gene there, not in a file it calls "gene.exp.diff".

      I guess it may do with the way isoforms are clumped up into genes. Maybe the algorithm misses some that are very different and therefore calls it a new gene?

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
        by SEQadmin2



        CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

        Despite this, “CRISPR helped turn genome editing from a specialized technique into
        ...
        07-31-2026, 11:01 AM
      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Today, 10:13 AM
      0 responses
      10 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-31-2026, 02:55 AM
      0 responses
      23 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-24-2026, 12:17 PM
      0 responses
      19 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-23-2026, 11:41 AM
      0 responses
      17 views
      0 reactions
      Last Post SEQadmin2  
      Working...